Ticker Scorecard - ALGS Basics Company: Aligos Therapeutics, Inc. IPO Date: October 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $93.39M Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 4.25% Avg Daily Range (30 D): $2.00 | 5.71% Avg Daily Range (90 D): $1.14 | 5.17% Institutional Daily Volume Avg Daily Volume: .03M Avg Daily Volume (30 D): .34M Avg Daily Volume (90 D): .31M Trade Size Avg Trade Size (Sh.): 26 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 83 Institutional Trades Total Inst.Trades: 98 Avg Inst. Trade: $2.45M Avg Inst. Trade (30 D): $.69M Avg Inst. Trade (90 D): $.79M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.3M Avg Closing Trade (30 D): $.69M Avg Closing Trade (90 D): $1.03M Avg Closing Volume: 13.54K     News Dec 13, 2024 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Aligos Therapeutics, Inc. Oct 11, 2024 @ 12:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: N/A Oct 1, 2024 @ 12:00 PM Aligos Therapeutics Appoints David Perry as Vice P... Source: N/A Sep 19, 2024 @ 12:00 PM Aligos Therapeutics Announces Positive Topline Res... Source: N/A Sep 18, 2024 @ 9:00 PM Aligos Therapeutics to Announce Topline Results fr... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-3.07 $.03 $-.22 Diluted EPS $-3.07 $.03 $-.22 Revenue $ 1.25M $ 1.06M $ .69M Gross Profit $ $ $ Net Income / Loss $ -19.26M $ 5.06M $ -34.86M Operating Income / Loss $ -20.13M $ -26.41M $ -22.05M Cost of Revenue $ $ $ Net Cash Flow $ -9.71M $ 20.78M $ -111.41M PE Ratio     Splits Aug 19, 2024:   25:1